4.6 Review

Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives

期刊

GLIA
卷 69, 期 3, 页码 513-531

出版社

WILEY
DOI: 10.1002/glia.23922

关键词

brain pathologies; central nervous system; demyelinating diseases; glial restricted precursor cells; spinal cord injury

资金

  1. FEDER, Competitiveness Internationalization Operational Program (POCI) [NORTE-01-0145-FEDER-000013, NORTE-01-0145-FEDER-029968, POCI-01-0145-FEDER-007038, POCI01-0145-FEDER-029206]
  2. Fundacao Bial [427/14]
  3. Fundacao para a Ciencia e a Tecnologia [IF/01079/2014, PTDC/MED-NEU/31417/2017]
  4. National Institute of Neurological Disorders and Stroke [1R01NS110385, 2R01NS079702]
  5. Nature Research Award for Driving Global Impact - 2019 Brain Sciences
  6. Premios Santa Casa Neurociencias - Prize Melo e Castro for Spinal Cord Injury Research [MC-04/17]
  7. Fundação para a Ciência e a Tecnologia [PTDC/MED-NEU/31417/2017] Funding Source: FCT

向作者/读者索取更多资源

Glial-restricted precursor cells (GRPs) are progenitors with differentiation potential restricted to the glial lineage in the central nervous system. These cells have been used in the treatment of various neurodegenerative and traumatic pathologies, showing promising results.
The crosstalk between glial cells and neurons represents an exceptional feature for maintaining the normal function of the central nervous system (CNS). Increasing evidence has revealed the importance of glial progenitor cells in adult neurogenesis, reestablishment of cellular pools, neuroregeneration, and axonal (re)myelination. Several types of glial progenitors have been described, as well as their potentialities for recovering the CNS from certain traumas or pathologies. Among these precursors, glial-restricted precursor cells (GRPs) are considered the earliest glial progenitors and exhibit tripotency for both Type I/II astrocytes and oligodendrocytes. GRPs have been derived from embryos and embryonic stem cells in animal models and have maintained their capacity for self-renewal. Despite the relatively limited knowledge regarding the isolation, characterization, and function of these progenitors, GRPs are promising candidates for transplantation therapy and reestablishment/repair of CNS functions in neurodegenerative and neuropsychiatric disorders, as well as in traumatic injuries. Herein, we review the definition, isolation, characterization and potentialities of GRPs as cell-based therapies in different neurological conditions. We briefly discuss the implications of using GRPs in CNS regenerative medicine and their possible application in a clinical setting. Main Points GRPs are progenitors present in the CNS with differentiation potential restricted to the glial lineage. These cells have been employed in the treatment of a myriad of neurodegenerative and traumatic pathologies, accompanied by promising results, herein reviewed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据